Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(2), P. 204 - 204
Published: Feb. 6, 2025
Advances
in
medical
nanobiotechnology
have
notably
enhanced
the
application
of
snake
venom
toxins,
facilitating
development
new
therapies
with
animal-derived
toxins.
The
vast
diversity
species
and
their
complexities
underline
need
for
ongoing
research.
This
review
is
dedicated
to
exploring
integration
nanoparticles
enable
use
human
aiming
develop
treatments.
complex
mixture
not
only
inflicts
significant
pathological
effects
but
also
offers
valuable
insights
creation
innovative
therapies,
particularly
realm
nanobiotechnology.
Nanoscale
encapsulation
mitigates
inherent
toxicity
amplifies
antitumoral,
antimicrobial,
immunomodulatory
properties.
synergy
between
venom-derived
macromolecules
nanotechnology
a
novel
pathway
augmenting
efficacy
safety
conventional
antivenom
extending
applicability
beyond
treating
bites
potentially
addressing
myriad
health
issues.
In
conclusion,
presents
compelling
therapeutic
frontier
that
promises
improve
current
treatment
modalities
ameliorate
adverse
associated
venomous
snakebites.
